These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 8302597

  • 21. Cyclin D1 is necessary but not sufficient for anchorage-independent growth of rat mammary tumor cells and is associated with resistance of the Copenhagen rat to mammary carcinogenesis.
    Li YJ, Song R, Korkola JE, Archer MC, Ben-David Y.
    Oncogene; 2003 May 29; 22(22):3452-62. PubMed ID: 12776197
    [Abstract] [Full Text] [Related]

  • 22. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
    Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, Sakamaki T, Pestell R, Bromberg J.
    Cancer Res; 2006 Mar 01; 66(5):2544-52. PubMed ID: 16510571
    [Abstract] [Full Text] [Related]

  • 23. Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein.
    Hall FL, Williams RT, Wu L, Wu F, Carbonaro-Hall DA, Harper JW, Warburton D.
    Oncogene; 1993 May 01; 8(5):1377-84. PubMed ID: 8479754
    [Abstract] [Full Text] [Related]

  • 24. BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation.
    Lukas J, Jadayel D, Bartkova J, Nacheva E, Dyer MJ, Strauss M, Bartek J.
    Oncogene; 1994 Aug 01; 9(8):2159-67. PubMed ID: 8036001
    [Abstract] [Full Text] [Related]

  • 25. Conditional transformation of rat embryo fibroblast cells by a cyclin D1-cdk4 fusion gene.
    Rao RN, Stamm NB, Otto K, Kovacevic S, Watkins SA, Rutherford P, Lemke S, Cocke K, Beckmann RP, Houck K, Johnson D, Skidmore BJ.
    Oncogene; 1999 Nov 04; 18(46):6343-56. PubMed ID: 10597234
    [Abstract] [Full Text] [Related]

  • 26. Ras-inducible immortalized fibroblasts: focus formation without cell cycle deregulation.
    Jacobsen K, Groth A, Willumsen BM.
    Oncogene; 2002 May 02; 21(19):3058-67. PubMed ID: 12082537
    [Abstract] [Full Text] [Related]

  • 27. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
    Yao D, Alexander CL, Quinn JA, Porter MJ, Wu H, Greenhalgh DA.
    Cancer Res; 2006 Feb 01; 66(3):1302-12. PubMed ID: 16452183
    [Abstract] [Full Text] [Related]

  • 28. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
    Akervall JA, Michalides RJ, Mineta H, Balm A, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F, Wennerberg JP.
    Cancer; 1997 Jan 15; 79(2):380-9. PubMed ID: 9010112
    [Abstract] [Full Text] [Related]

  • 29. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
    Jares P, Campo E, Pinyol M, Bosch F, Miquel R, Fernandez PL, Sanchez-Beato M, Soler F, Perez-Losada A, Nayach I, Mallofré C, Piris MA, Montserrat E, Cardesa A.
    Am J Pathol; 1996 May 15; 148(5):1591-600. PubMed ID: 8623927
    [Abstract] [Full Text] [Related]

  • 30. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein.
    Bartkova J, Lukas J, Strauss M, Bartek J.
    J Pathol; 1994 Mar 15; 172(3):237-45. PubMed ID: 8195927
    [Abstract] [Full Text] [Related]

  • 31. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ, Austin VN, Zimmer SG, Fisher PB.
    Oncogene; 1993 May 15; 8(5):1211-9. PubMed ID: 8479744
    [Abstract] [Full Text] [Related]

  • 32. Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells.
    Al Moustafa AE, Foulkes WD, Wong A, Jallal H, Batist G, Yu Q, Herlyn M, Sicinski P, Alaoui-Jamali MA.
    Oncogene; 2004 Jul 01; 23(30):5252-6. PubMed ID: 15229656
    [Abstract] [Full Text] [Related]

  • 33. Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.
    Garcia-España A, Salazar E, Sun TT, Wu XR, Pellicer A.
    Cancer Res; 2005 Feb 15; 65(4):1150-7. PubMed ID: 15734997
    [Abstract] [Full Text] [Related]

  • 34. Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1.
    Kröger A, Stirnweiss A, Pulverer JE, Klages K, Grashoff M, Reimann J, Hauser H.
    Cancer Res; 2007 Apr 01; 67(7):2972-81. PubMed ID: 17409403
    [Abstract] [Full Text] [Related]

  • 35. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
    Woo RA, Poon RY.
    Genes Dev; 2004 Jun 01; 18(11):1317-30. PubMed ID: 15175263
    [Abstract] [Full Text] [Related]

  • 36. Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth.
    Han EK, Sgambato A, Jiang W, Zhang YJ, Santella RM, Doki Y, Cacace AM, Schieren I, Weinstein IB.
    Oncogene; 1995 Mar 02; 10(5):953-61. PubMed ID: 7898937
    [Abstract] [Full Text] [Related]

  • 37. Overexpression of cyclin D1 in epithelial ovarian cancers.
    Worsley SD, Ponder BA, Davies BR.
    Gynecol Oncol; 1997 Feb 02; 64(2):189-95. PubMed ID: 9038263
    [Abstract] [Full Text] [Related]

  • 38. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats.
    Weroha SJ, Li SA, Tawfik O, Li JJ.
    Carcinogenesis; 2006 Mar 02; 27(3):491-8. PubMed ID: 16311245
    [Abstract] [Full Text] [Related]

  • 39. Oncogenic activation of a human cyclin A2 targeted to the endoplasmic reticulum upon hepatitis B virus genome insertion.
    Berasain C, Patil D, Perara E, Huang SM, Mouly H, Bréchot C.
    Oncogene; 1998 Mar 12; 16(10):1277-88. PubMed ID: 9546429
    [Abstract] [Full Text] [Related]

  • 40. Cyclin D1 and p21/waf1 are both involved in p53 growth suppression.
    Del Sal G, Murphy M, Ruaro E, Lazarevic D, Levine AJ, Schneider C.
    Oncogene; 1996 Jan 04; 12(1):177-85. PubMed ID: 8552389
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.